160 related articles for article (PubMed ID: 26569091)
1. The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation.
Ladas EJ; Bhatia M; Chen L; Sandler E; Petrovic A; Berman DM; Hamblin F; Gates M; Hawks R; Sung L; Nieder M
Bone Marrow Transplant; 2016 Feb; 51(2):262-6. PubMed ID: 26569091
[TBL] [Abstract][Full Text] [Related]
2. Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over-the-counter probiotic formulations.
Cohen SA; Woodfield MC; Boyle N; Stednick Z; Boeckh M; Pergam SA
Transpl Infect Dis; 2016 Oct; 18(5):699-705. PubMed ID: 27501401
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).
Efebera YA; Geyer S; Andritsos L; Vasu S; Jaglowski S; Bingman A; Blum W; Klisovic R; Hofmeister CC; Benson DM; Penza S; Elder P; Cortright K; Kitzler R; Coombes K; O'Donnell L; Daneault B; Bradbury H; Zhang J; Chen X; Garman S; Ranganathan P; Yu X; Hofstetter J; Yu J; Garzon R; Scrape SR; Lozanski G; Devine SM
Biol Blood Marrow Transplant; 2016 Jan; 22(1):71-9. PubMed ID: 26256940
[TBL] [Abstract][Full Text] [Related]
4. Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial.
Maziarz RT; Devos T; Bachier CR; Goldstein SC; Leis JF; Devine SM; Meyers G; Gajewski JL; Maertens J; Deans RJ; Van't Hof W; Lazarus HM
Biol Blood Marrow Transplant; 2015 Apr; 21(4):720-8. PubMed ID: 25555450
[TBL] [Abstract][Full Text] [Related]
5. Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials.
Johnston BC; Supina AL; Vohra S
CMAJ; 2006 Aug; 175(4):377-83. PubMed ID: 16908901
[TBL] [Abstract][Full Text] [Related]
6. Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies.
Naik S; Martinez C; Leung K; Sasa G; Nguyen NY; Wu MF; Gottschalk S; Brenner M; Heslop H; Krance R
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1266-72. PubMed ID: 25765555
[TBL] [Abstract][Full Text] [Related]
7. Probiotics for prevention and treatment of diarrhea.
Guandalini S
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S149-53. PubMed ID: 21992955
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host disease.
Goldberg J; Jacobsohn DA; Zahurak ML; Vogelsang GB
Biol Blood Marrow Transplant; 2005 Feb; 11(2):101-7. PubMed ID: 15682070
[TBL] [Abstract][Full Text] [Related]
9. Viral PCR positivity in stool before allogeneic hematopoietic cell transplantation is strongly associated with acute intestinal graft-versus-host disease.
van Montfrans J; Schulz L; Versluys B; de Wildt A; Wolfs T; Bierings M; Gerhardt C; Lindemans C; Wensing A; Boelens JJ
Biol Blood Marrow Transplant; 2015 Apr; 21(4):772-4. PubMed ID: 25598276
[TBL] [Abstract][Full Text] [Related]
10. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.
Bhatia M; Militano O; Jin Z; Figurski M; Shaw L; Moore V; Morris E; Tallamy B; van deVen C; Ayello J; Baxter-Lowe L; Satwani P; George D; Bradley MB; Garvin J; Cairo MS
Biol Blood Marrow Transplant; 2010 Mar; 16(3):333-43. PubMed ID: 19835971
[TBL] [Abstract][Full Text] [Related]
11. Chimerism-based pre-emptive immunotherapy with fast withdrawal of immunosuppression and donor lymphocyte infusions after allogeneic stem cell transplantation for pediatric hematologic malignancies.
Horn B; Petrovic A; Wahlstrom J; Dvorak CC; Kong D; Hwang J; Expose-Spencer J; Gates M; Cowan MJ
Biol Blood Marrow Transplant; 2015 Apr; 21(4):729-37. PubMed ID: 25644958
[TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients.
Osunkwo I; Bessmertny O; Harrison L; Cheung YK; Van de Ven C; del Toro G; Garvin J; George D; Bradley MB; Wolownik K; Wischhover C; Levy J; Skerrett D; Cairo MS
Biol Blood Marrow Transplant; 2004 Apr; 10(4):246-58. PubMed ID: 15077223
[TBL] [Abstract][Full Text] [Related]
14. Incidence and causes of hospital readmission in pediatric patients after hematopoietic cell transplantation.
Shulman DS; London WB; Guo D; Duncan CN; Lehmann LE
Biol Blood Marrow Transplant; 2015 May; 21(5):913-9. PubMed ID: 25667988
[TBL] [Abstract][Full Text] [Related]
15. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
De Seta F; Parazzini F; De Leo R; Banco R; Maso GP; De Santo D; Sartore A; Stabile G; Inglese S; Tonon M; Restaino S
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():136-9. PubMed ID: 25305660
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study.
Yeshurun M; Shpilberg O; Herscovici C; Shargian L; Dreyer J; Peck A; Israeli M; Levy-Assaraf M; Gruenewald T; Mechoulam R; Raanani P; Ram R
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1770-5. PubMed ID: 26033282
[TBL] [Abstract][Full Text] [Related]
17. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Avanzini MA; Maccario R; Locatelli F; Giebel S; Santos CD; Bernardo ME; Pagliara D; Montagna D; Longo S; Amendola G; Marconi M
Exp Hematol; 2006 Oct; 34(10):1429-34. PubMed ID: 16982336
[TBL] [Abstract][Full Text] [Related]
18. Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation.
Andermann TM; Rezvani A; Bhatt AS
Curr Hematol Malig Rep; 2016 Feb; 11(1):19-28. PubMed ID: 26780719
[TBL] [Abstract][Full Text] [Related]
19. Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host disease.
Vaughn JE; Gooley T; Maziarz RT; Pulsipher MA; Bhatia S; Maloney DG; Sandmaier BM; Flowers ME; Storb R; Sorror ML
Br J Haematol; 2015 Nov; 171(3):411-6. PubMed ID: 26194447
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines.
Aldenhoven M; Jones SA; Bonney D; Borrill RE; Coussons M; Mercer J; Bierings MB; Versluys B; van Hasselt PM; Wijburg FA; van der Ploeg AT; Wynn RF; Boelens JJ
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1106-9. PubMed ID: 25708213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
